Single-Use Assemblies (SUAs)

A single-use assembly (SUA) is a pre-fabricated, pre-sterilized fluid-path component — typically some combination of flexible tubing, bags, connectors, filters, and sensors — manufactured, irradiated, and supplied ready to install into a bioprocess for exactly one production run before being discarded, rather than cleaned and reused. For a research administrator, lab manager, or procurement officer, the practical question an SUA purchase raises is rarely just “does it fit the tubing size” — it is whether the assembly’s manufacturer can produce the documentation (sterilization validation, extractables and leachables data, change-control history) that a GMP or GMP-adjacent process needs to qualify it as a controlled component, not just a disposable commodity.

What makes something a single-use assembly, specifically

Three things separate an SUA from ordinary disposable labware:

• It is pre-configured for a defined fluid path. An SUA is built to a specification — tubing diameter and material (commonly platinum-cured silicone or thermoplastic elastomer), connector types (sterile welds, aseptic connectors, or quick-disconnects), filter or sensor ports — rather than assembled from generic stock at the point of use.
• It is terminally sterilized as a unit. The whole assembly, not just its individual components, is validated as sterile (almost always by gamma or e-beam irradiation) before it ships, so it can go directly into an aseptic process without in-process cleaning-in-place (CIP) or steam-in-place (SIP).
• It is qualified with supporting documentation, not just a certificate of conformance. For GMP or GMP-adjacent use, the buyer needs evidence the assembly won’t introduce contaminants or interact with the product — principally an extractables and leachables (E&L) data package and a documented, auditable manufacturing and change-control history.

Single-use assemblies vs. single-use bioprocessing systems

The terms are related but not interchangeable, and buyers evaluating a supplier’s catalog should keep the distinction straight:

• Single-use assembly usually refers to a specific, often custom-configured tubing/bag/connector/filter set — the equivalent of a specified fluid-transfer or sampling line.
• Single-use bioprocessing is the broader manufacturing approach: replacing stainless-steel, CIP/SIP-cleaned hardware with disposable plastic components across an entire unit operation or process train — single-use bioreactors, mixing systems, bag-based storage and hold vessels, single-use filtration and chromatography skids, and the assemblies (tubing, connectors) that link them together.

In practice, an SUA is one component within a broader single-use bioprocessing strategy. A facility can adopt single-use bioprocessing for some unit operations (e.g., upstream cell culture in single-use bioreactors) while still using stainless-steel, reusable hardware elsewhere, with SUAs as the connecting fluid-transfer components between them.

Standards and regulatory documentation to evaluate before procuring

There is no single certifying body for single-use assemblies the way there is for, say, pressure vessels — qualification instead rests on a buyer assembling evidence against several overlapping standards and industry protocols. What to ask a supplier for:

• ASTM E3051, the standard guide for the application of single-use systems in pharmaceutical and biopharmaceutical manufacturing — a widely referenced framework for how single-use components should be specified, qualified, and change-controlled across their lifecycle.
• USP General Chapter <665>, “Plastic Components and Systems Used to Manufacture Pharmaceutical and Biopharmaceutical Drug Products,” which sets physicochemical and extractables testing expectations for the plastic materials in contact with the product stream, and the related informational chapter USP <1665>, which gives guidance on the risk-based approach to generating that extractables data.
• USP <1207> (package/container closure integrity) where the assembly also functions as primary packaging or a sterile barrier for hold or storage.
• ISO 11137, the standard for radiation sterilization of health-care products, which underpins how a supplier validates and documents the gamma or e-beam dose applied to reach the assembly’s stated sterility assurance level (SAL).
• ISO 13485, the quality-management-system standard for medical device and component manufacturers — ask whether the SUA manufacturer’s facility is certified to it; it is the closest available proxy for manufacturing-process control and change-management discipline in this space.
• The BioPhorum Operations Group (BPOG) extractables protocol, an industry-consensus testing protocol that many single-use suppliers now run their materials against, giving buyers a comparable extractables data set across vendors rather than each supplier’s own bespoke test design.

None of these is a single go/no-go stamp; a genuine qualification decision means requesting the underlying data (E&L reports, gamma dose-mapping studies, ISO 13485 certificates, change-notification history) rather than accepting a one-line compliance claim.

What to evaluate when qualifying a supplier or a specific assembly

• Extractables and leachables (E&L) data. Has the supplier tested the actual materials in your assembly’s fluid path (not just a generic film or resin), ideally to the BPOG protocol or an equivalent risk-based extractables study, with data specific enough to support your own leachables risk assessment?
• Sterility assurance and dose mapping. What SAL is validated for the assembly, and is the gamma or e-beam dose mapped and documented per ISO 11137 for this specific configuration — not just for a “similar” product?
• Change notification policy. Single-use suppliers periodically change resins, film suppliers, or manufacturing sites. Does the supplier commit, contractually, to notify customers of changes that could affect fit, function, or extractables profile before shipping the changed product — and how much lead time do you get to re-qualify?
• Traceability and lot documentation. Can every assembly be traced to specific component lots, sterilization batch records, and inspection results, in case an investigation is needed later?
• Single-source and supply-continuity risk. Single-use consumables are typically single-sourced per configuration once qualified, because re-qualifying an alternate supplier’s assembly is its own project. Ask about the supplier’s own resin/film supply-chain resilience and whether a bridging or comparability study path exists if you ever need a second source.
• Quality agreement and audit rights. For GMP use, a formal quality agreement covering specifications, deviation notification, and audit access is standard practice, not an optional extra.
• Fit against your process, not just your budget. The cheapest assembly that meets a nominal spec is a false economy if its E&L or change-control documentation is thin — the downstream cost of a failed qualification, a batch investigation, or an unannounced material change is almost always larger than the per-unit price difference between suppliers.

The sustainability trade-off worth naming

Single-use assemblies trade cleaning validation, water use, and cross-contamination risk for increased plastic waste and reliance on a longer, more specialized supply chain (resin producers, film converters, gamma-irradiation contract sites). That trade-off is a legitimate part of a procurement decision, not a side issue — some facilities now formally weigh it as part of sustainable procurement policy alongside the traditional qualification criteria above, particularly when comparing a single-use strategy against a reusable, CIP/SIP stainless system for a given unit operation.

Examples

• A biomanufacturing team orders a pre-sterilized bag-and-tubing manifold, gamma-irradiated and fitted with sterile connectors, to transfer buffer from a mixing vessel to a chromatography skid without cleaning-in-place between batches — a straightforward single-use assembly.
• A cell-therapy production suite requires a documented extractables and leachables data package from the assembly manufacturer, tested against the BPOG protocol, before it will qualify a new tubing set for use in its GMP process — rather than accepting a supplier’s certificate of conformance alone.

What a single-use assembly is not

A stainless-steel tri-clamp tubing run that is cleaned-in-place and steam-sterilized-in-place between batches is a reusable, hard-piped system, not a single-use assembly, even if it uses similar tri-clamp connector hardware. Likewise, a general-purpose disposable pipette tip, petri dish, or centrifuge tube is single-use plasticware, but it is not a “single-use assembly” in the procurement/regulatory sense used above — that term specifically denotes a pre-configured, validated fluid-path component (tubing, bags, connectors, filters) supplied for a bioprocess, with the sterilization-validation and extractables documentation that implies, not any disposable lab consumable.

Frequently asked questions

What is single-use bioprocessing?

Single-use bioprocessing is the broader manufacturing strategy of replacing stainless-steel, CIP/SIP-cleaned process hardware with pre-sterilized, disposable plastic components — bioreactors, mixing and storage bags, filtration and chromatography skids, and the single-use assemblies that connect them — across some or all of a bioprocess. Single-use assemblies are the tubing, connector, and bag components used within that strategy.

Are all single-use assemblies sterile?

Assemblies intended for aseptic or GMP use are terminally sterilized (almost always gamma or e-beam irradiated) and supplied with a validated sterility assurance level. Not every disposable tubing or bag product on the market is sold at that validated sterility grade, though, so “single-use” alone does not guarantee it — confirm the sterilization method and SAL documentation for the specific product and configuration you are buying, rather than assuming it from the product category.

Why does gamma dose validation matter for procurement, specifically?

The sterility claim on an assembly is only as good as the dose-mapping study behind it. A dose validated for one configuration (a given wall thickness, fill density, or bag geometry) does not automatically transfer to a different configuration from the same supplier, which is why buyers should confirm ISO 11137 dose mapping was performed for their specific assembly, not a nominally similar one.

Do single-use assemblies need to comply with USP <665>?

USP <665> applies to plastic components and systems used to manufacture pharmaceutical and biopharmaceutical drug products, so an SUA used in that context is expected to have supporting data against it (or the related risk-based guidance in USP <1665>). An SUA used purely in a research or non-GMP process is not legally bound by USP chapters the way a licensed drug manufacturer is, but many research and process-development groups still request the same data package to de-risk later scale-up and technology transfer into a GMP setting.

Related terms

Good Manufacturing Practice (GMP), GxP Compliance, ICH Q7, Cleanroom Classifications, and Cell Culture Basics cover the surrounding manufacturing and lab-operations context this term sits within.